Chronic progressive calcineurin nephrotoxicity: an overstated concept.
about
Factors influencing long-term outcome after kidney transplantationReconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomesCyclosporine: a review.Minimization vs tailoring: Where do we stand with personalized immunosuppression during renal transplantation in 2015?Challenges and considerations in diagnosing the kidney disease in deteriorating graft function.Calcineurin inhibitors: short-term friend, long-term foe?Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocolTacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF GenomicsEarly Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study.The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.A drug safety evaluation of everolimus in kidney transplantation.Belatacept utilization recommendations: an expert position.The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.Conversion from calcineurin inhibitor-based immunosuppression to mammalian target of rapamycin inhibitors or belatacept in renal transplant recipients.Immunosuppressive properties of a series of novel inhibitors of the monocarboxylate transporter MCT-1.Late kidney dysfunction in a kidney transplant recipientMoving Beyond Minimization Trials in Kidney Transplantation.Long-term outcomes following sirolimus conversion after renal transplantation.Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial.Clinical and immunological features of very long-term survivors with a single renal transplant.Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen.Use of belatacept to maintain adequate early immunosuppression in calcineurin-mediated microangiopathic hemolysis post-renal transplantBelatacept: a novel immunosuppressive agent for kidney transplant recipientsPathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney TransplantationImpact of reduced exposure to calcineurin inhibitors on the development of de novo DSA: a cohort of non-immunized first kidney graft recipients between 2007 and 2014
P2860
Q26825480-872436C6-D4D2-4D0D-8A8D-60808415024FQ28080994-4BBD3A03-3E44-47F3-99CD-147ECA429D74Q35675934-083008DB-768C-4D43-8995-C39EE77D0861Q36087779-C42E7D5E-B537-4101-AE56-184A6A3A3AC2Q36365811-005DFFA4-A905-47B2-A5ED-06B31590DAAAQ36769749-139892AA-F3F4-4C33-84AD-6300FF0E3C6FQ36908763-D6163D25-6479-48CA-B8C3-5A6AAC7BFFD6Q37209745-12E4997F-7890-43AE-B7B9-B6EE08794558Q37346593-615D5C7E-A361-4779-AD5A-C12CA625CCD6Q38003049-E8859436-B82F-45E8-9766-F79BB02DFD19Q38041260-B94820FF-3C85-4E96-9AE0-9139859849A4Q38064538-194D5E97-904D-418C-890F-8CB545662BE0Q38163945-75757745-4E7B-491D-B7A3-1ED1C10F6E61Q38241710-E12D5C7F-0F4D-45CB-936E-E9F465E253B2Q39523192-8403A632-3EFB-4027-8CF0-DB3A633E93B4Q41834576-16CD7B1B-751B-483A-AF4D-00BC69C1ACE6Q43158054-DB63E445-A8B1-47EA-8F5E-8F327020033DQ44544352-46E6E355-30DB-45DD-BCC6-B592A649B52EQ47309233-4958171C-4B7C-4656-8B21-5600FC2E2CD4Q50966306-E8C4074A-9BB6-4F85-A786-0E57F93F2019Q54411021-86097D86-D071-4526-BF71-C6D47438D860Q56896789-FDBFA7FD-EC94-462A-AF36-1E0CDF26663CQ56897769-2312A040-20BA-4F23-AA17-B9264E9C995AQ57151742-4697D499-CAC0-4FF8-996E-5BEF894EE017Q58737637-19FB040E-13E7-4B41-8BCC-70954CE068CC
P2860
Chronic progressive calcineurin nephrotoxicity: an overstated concept.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Chronic progressive calcineurin nephrotoxicity: an overstated concept.
@ast
Chronic progressive calcineurin nephrotoxicity: an overstated concept.
@en
type
label
Chronic progressive calcineurin nephrotoxicity: an overstated concept.
@ast
Chronic progressive calcineurin nephrotoxicity: an overstated concept.
@en
prefLabel
Chronic progressive calcineurin nephrotoxicity: an overstated concept.
@ast
Chronic progressive calcineurin nephrotoxicity: an overstated concept.
@en
P2860
P1476
Chronic progressive calcineurin nephrotoxicity: an overstated concept.
@en
P2093
Arthur J Matas
P2860
P304
P356
10.1111/J.1600-6143.2011.03505.X
P407
P577
2011-04-01T00:00:00Z